Navidea Biopharmaceuticals, Inc. Made Headway
Fri, May 22, 2020 at 05:30 PM
Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) soared at $2.43, a gain of 91.3%. The stock got featured on our News Catalysts scanner on Fri 22 May 20 at 01:19 PM in the 'MISCELLANEOUS' category. From Thu 07 May 20, the stock recorded 40.00% Up Days and 54.55% Green Days
About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
Top 10 Gainers:
- Yunhong International (ZGYH:NASDAQ), 100%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 91.34%
- XpresSpa Group, Inc. (XSPA:NASDAQ), 70.21%
- Sundial Growers Inc. (SNDL:NASDAQ), 39.69%
- Renren Inc. (RENN:NYSE), 38.03%
- Genesis Healthcare, Inc. (GEN:NYSE), 35.06%
- Mitcham Industries, Inc. (MIND:NASDAQ), 32.03%
- Celsion Corporation (CLSN:NASDAQ), 28.94%
- Xeris Pharmaceuticals, Inc. (XERS:NASDAQ), 28.04%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 27.45%